Dendrimer-conjugated podophyllotoxin suppresses DENA-induced HCC progression by modulation of inflammatory and fibrogenic factors

Toxicology Research
Supriya SharmaUgir Hossain Sk

Abstract

Podophyllotoxin has been explored as an anticancer, antiviral, and antibacterial agent; however, its low water solubility and toxicity limit its use. In this study, the efficacy of a more soluble and less toxic polyamidoamine (PAMAM) dendrimer-conjugated podophyllotoxin (DPODO) was evaluated against chemically induced hepatocellular carcinoma (HCC) in mice. HCC was induced by giving 0.01% diethylnitrosamine (DENA) in drinking water for 16 weeks. The HCC-induced mice were treated with 10 or 20 mg per kg body weight DPODO. The DENA administration led to HCC development, characterized by anisocytosis, karyomegaly, inflammation and degenerative changes in the liver. The DPODO treatment at 10 mg and 20 mg doses significantly reduced the histopathological changes in liver tissue. The DPODO treatment also significantly lowered the levels of inflammatory markers IL-6 and NF-κB in serum and tissue, respectively. Further, the treatment also significantly reduced fibrous tissue deposition in the liver, which was further confirmed by the reduced mRNA levels and tissue expression of fibrogenic markers TGF-β and α-SMA in the liver. The results of the present study indicate that DPODO treatment suppresses the progression of HCC by modulating ...Continue Reading

References

Aug 11, 2004·Toxicon : Official Journal of the International Society on Toxinology·M GordalizaM A Gómez-Zurita
Dec 8, 2005·Nature Biotechnology·Cameron C LeeFrancis C Szoka
May 23, 2006·Journal of Hepatology·Derek A Mann, Fiona Oakley
Jul 13, 2006·Nano Letters·Vladimir S TalanovMartin W Brechbiel
Aug 19, 2007·Pharmaceutical Research·Kelly M KitchensHamidreza Ghandehari
Mar 19, 2009·World Journal of Gastroenterology : WJG·Salim S Al-RejaieMohamed M Sayed-Ahmed
Oct 19, 2011·Cell and Tissue Research·Steven Dooley, Peter ten Dijke
Nov 9, 2012·International Journal of Biological Sciences·Stefan Rose-John
Sep 3, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ling YangEkihiro Seki
Jul 19, 2014·Journal of Pharmacy & Bioallied Sciences·Kanika MadaanDeepti Pandita
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Jul 3, 2015·Biomolecular Concepts·Ugir Hossain Sk, Chie Kojima
Aug 19, 2015·Environmental Toxicology and Pharmacology·Vikram PatialYogendra S Padwad
Oct 24, 2015·Nature Reviews. Cancer·Jens U MarquardtSnorri S Thorgeirsson
Feb 13, 2016·Journal of Hepatology·Dirk Schmidt-Arras, Stefan Rose-John
Feb 20, 2016·Drug Design, Development and Therapy·Monika A PapieżAlicja Jozkowicz
Oct 22, 2016·Pharmaceutical Research·Izabela Jatczak-PawlikBarbara Klajnert-Maculewicz
Oct 23, 2016·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Juri BergmannDirk Schmidt-Arras
May 10, 2017·Journal of Gastrointestinal Oncology·Philippe J ZamorMark W Russo
Aug 27, 2017·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Vikram PatialUgir Hossain Sk
Feb 23, 2018·The Journal of Pharmacology and Experimental Therapeutics·Jie GaoHai-Ling Qiao

❮ Previous
Next ❯

Citations

Aug 28, 2021·Frontiers in Cell and Developmental Biology·Hua-Yang FanXin-Hua Liang

❮ Previous
Next ❯

Methods Mentioned

BETA
NMR
column chromatography
ELISA

Software Mentioned

Primer express
ImageJ

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.